Sunday, August 02, 2020 11:28:22 PM
They own the rights to the patent yes they do. Check back in the filings. “
Well that was wrong. Gpft does not own the IP by any stretch. The small pharma is the patent holder and is purportedly licensing out this tech to gpft for 100% of USA .All of this reported by gpft not Zylo therapeutics and no 8k accompanied any of it. If zylo has the nutflush for smokeless Thc delivery then they would be idiotic to get in bed with only one weak otc company years away from profitability... unless of course gpft forked over a giant chunk of change. I’ve seen the books and didn’t to see any 100M licensing fee.
The Q will be more of the same. Mounting losses and unsustainable cash combustion. COVID will come in handy and another excuse!
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM